Adele Schwartz Benzaken

Abstract Human papillomavirus vaccination is central to cervical cancer elimination, yet population-level evidence from middle-income countries remains limited. We evaluated the impact of quadrivalent HPV vaccination in Brazil using data from two repeated population-based cross-sectional surveys conducted in 2016–2017 and 2020–2023 among sexually active individuals aged 16–25 years.

INTRODUCTION Although data on HIV morbidity and mortality show that significant progress has been achieved globally in recent decades, alarming epidemiologic evidence underscore that key goals remain unaccomplished. The World Health Organization (WHO) estimates that approximately 630 000 people died of HIV-related causes in 2022, including 84 000 children [1]. HIV-related mortality is avertable, inasmuch as diagnostic tools and effective therapeutic interventions are accessible to those in need.

This is an early access version, the complete PDF, HTML, and XML versions will be available soon. Open AccessArticle by Rosana Moysés 1,2, Inês Marques 1, B. Daiana Santos 1, Adele Benzaken 3 and M.